STING1 and neoplasm: This review focuses on the rationale behind, and the effects mediated by STING agonists in cancer treatment, by exploring how STING agonists have the potential to convert a “cold” tumor site into a pro‐inflammatory “hot” TME, which makes it an interesting partner in immunotherapy.